Qiqiang Liang
- Topics
- Antibiotic Resistance in Bacteria (6 papers)Bacterial Identification and Susceptibility Testing (5 papers)Sepsis Diagnosis and Treatment (4 papers)
- Partner nations
- ChinaUnited KingdomAustralia
In The Last Decade
Qiqiang Liang
16 papers receiving 308 citations
Peers
Comparison fields: 5 of 62
- Molecular Medicine 157
- Epidemiology 70
- Pharmacology 62
- Molecular Biology 48
- Clinical Biochemistry 48
Countries citing papers authored by Qiqiang Liang
This map shows the geographic impact of Qiqiang Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiqiang Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiqiang Liang more than expected).
Fields of papers citing papers by Qiqiang Liang
This network shows the impact of papers produced by Qiqiang Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiqiang Liang. The network helps show where Qiqiang Liang may publish in the future.
Co-authorship network of co-authors of Qiqiang Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Qiqiang Liang. A scholar is included among the top collaborators of Qiqiang Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiqiang Liang. Qiqiang Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 30 | |
| 8 | 10 | |
| 9 | Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection | 33 |
| 10 | 10 | |
| 11 | 22 | |
| 12 | 11 | |
| 13 | 5 | |
| 14 | 51 | |
| 15 | 30 | |
| 16 | 31 | |
| 17 | 15 | |
| 18 | 46 |
About Qiqiang Liang
Qiqiang Liang is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 18 papers that have together received 310 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Sepsis Diagnosis and Treatment (4 papers). The work is most often cited by research in Molecular Medicine (157 citations), Applied Microbiology and Biotechnology (47 citations) and Clinical Biochemistry (48 citations). Qiqiang Liang has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Man Huang, Dongni Li, Youjun Feng, Lizhang Liu, Juan Chen, Wugao Liu, Wei Wang, Xin Xu, Yun Ge and Beiwen Zheng. Their work appears in journals such as SHILAP Revista de lepidopterología, Medicine and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.